Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHDBenjamin Watkins, Leslie S. Kean, Scott N. Furlan et al.|Journal of Clinical Oncology|2021Cited by 255
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse eventsTakuto Takahashi, Leslie S. Kean, Mahmoud Al‐Kofahi et al.|Blood|2023Cited by 16
T Cell Costimulation Blockade with CTLA4-Ig (Abatacept) for Acute Gvhd Prevention in HLA Matched and Mismatched Unrelated Donor Transplantation: Results of the First Phase 2 TrialBen Watkins, Leslie S. Kean, Muna Qayed et al.|Transplantation and Cellular Therapy|2019Cited by 11
Comparable Outcomes for Matched and Mismatched Unrelated Donor (URD) Transplantation with the Addition of Abatacept to Standard Graft Versus Host Disease ProphylaxisMuna Qayed, John Horan, Benjamin Watkins et al.|Transplantation and Cellular Therapy|2021Cited by 0